EPISODE · Jun 22, 2020 · 8 MIN
The FDA Revokes Its Emergency Use Authorization for Hydroxychloroquine
from Science, Spoken · host SpokenLayer
So far, no studies have shown that the anti-malarial drug can fight Covid-19, and agency officials say its potential benefits do not outweigh its risks. Learn about your ad choices: dovetail.prx.org/ad-choices
What this episode covers
So far, no studies have shown that the anti-malarial drug can fight Covid-19, and agency officials say its potential benefits do not outweigh its risks.
NOW PLAYING
The FDA Revokes Its Emergency Use Authorization for Hydroxychloroquine
No transcript for this episode yet
Similar Episodes
No similar episodes found.